Prediction of late failure after medical abortion from serial β-hCG measurements and ultrasonography

Human Reproduction

Volumn 19, Issue 1, 2004, Pages 85-89

  Rørbye, Christina ^a   Norgaard M ^a   Nilas, L ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Diagnostic test; Failure; Medical abortion; Prediction; hCG

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; GEMEPROST; MIFEPRISTONE;

ADULT; ARTICLE; BLEEDING; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ENDOMETRIUM; FEMALE; FOLLOW UP; GESTATIONAL AGE; GONADOTROPIN BLOOD LEVEL; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; PREDICTION; PROGNOSIS; THERAPEUTIC ABORTION; THICKNESS; TRANSVAGINAL ECHOGRAPHY; TREATMENT FAILURE;

EID: 0347946705     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh041     Document Type: Article

References (27)

1. Ashok PW, Penney GC, Flett GM et al. (1998) An effective regimen for early medical abortion: A report of 2000 consecutive cases. Hum Reprod 13,2962-2965.
2. Ashok PW, Templeton A, Wagaarachchi PT et al. (2002) Factors affecting the outcome of early medical abortion: A review of 4132 consecutive cases. Br J Obstet Gynecol 109,1281-1289.
3. Aubeny E, Peyron R, Turpin CL et al. (1995) Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [corrected]. Int. J. Fertil. Menopausal Stud., 40(Suppl 2),85-91.
4. Bartley J, Tong S, Everington D et al. (2000) Parity is a major determinant of success rate in medical abortion: A retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 62,297-303.
5. Bartley J, Brown A, Elton R et al. (2001) Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation. Hum Reprod 16,2098-2102.
6. Child TJ, Thomas J., Rees M. et al. (2001) A comparative study of surgical and medical procedures: 932 pregnancy terminations up to 63 days gestation. Hum Reprod 16,67-71.
7. Creinin MD (1996) Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol. Am J Obstet Gynecol 174,776-778.
8. Grimes DA, Bernstein L, Lacarra M et al. (1990) Predictors of failed attempted abortion with the antiprogestin mifepristone (RU 486). Am J Obstet Gynecol 162,910-915.
9. Harwood B, Meckstroth KR, Mishell DR et al. (2001) Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion. Contraception 63,255-256.
10. Henshaw RC, Naji SA, Russell IT et al. (1994) A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: Efficacy and early medical sequelae. Hum Reprod 9,2167-2172.
11. Honkanen H, Ranta S, Ylikorkala O et al. (2002) The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy. Hum Reprod 17,2315-2319.
12. Jensen JT, Astley SJ, Morgan E et al. (1999) Outcomes of suction curettage and mifepristone abortion in the United States. A prospective comparison study. Contraception 59,153-159.
13. Kahn JG, Becker BJ, MacIsaa L et al. (2000) The efficacy of medical abortion: A meta-analysis. Contraception 61,29-40.
14. Knudsen UB (2001) First trimester abortion with mifepristone and vaginal misoprostol. Contraception 63,247-250.
15. McKinley C, Thong KJ and Baird DT (1993) The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 8, 1502-1505.
16. Rørbye C, Nørgaard M and Nilas L (2003) Medical abortion - Defining success and categorizing failures. Contraception, 68,247-251.
17. Schaff EA, Eisinger SH, Stadalius LS et al. (1999) Los-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 59,1-6.
18. Schaff EA, Fielding SL, Westhoff C et al. (2000a) Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial. J Am Med Assoc 284,1948-1953.
19. Schaff EA, Fielding SL, Eisinger SH et al. (2000b) Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 61,41-46.
20. Somell C, Olund A, Carlstrom K et al. (1990) Reproductive hormones during termination of early pregnancy with mifepristone. Gynecol Obstet Invest 30,224-227.
21. Spitz, IM, Bardin CW, Benton, L et al. (1998) Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 338,1241-1247.
22. Thonneau P, Fougeyrollas B, Ducot B et al. (1998) Complications of abortion performed under local anesthesia. Eur J Obstet Gynecol Reprod Biol 81,59-63.
23. UK Multicentre Trial (1990) The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. Br J Obstet Gynecol 97,480-486.
24. Walker K, Schaff E, Fielding S et al. (2001) Monitoring serum chorionic gonadotropin levels after mifepristone abortion. Contraception 64,271-273.
25. Winikoff B, Sivin I, Coyaji KJ et al. (1997) Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: A comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol 176,431-437.
26. Wong SF, Lam MH and Ho LC (2002) Transvaginal sonography in the detection of retained products of conception after first-trimester spontaneous abortion. J Clin Ultrasound 30,428-432.
27. World Health Organization Task Force (1991) Pregnancy termination with mifepristone and gemeprost: A multicenter comparison between repeated doses and a single dose of mifepristone. Fertil Steril 56,32-40.